Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cureus|September 21, 2022
Exploring a New Entity of Single-Agent Pembrolizumab-Associated HypophysitisEric Balti, Sarah Verhaeghe, Vibeke Kruse, et al.
Cureus|March 22, 2024
Correction: Exploring a New Entity of Single-Agent Pembrolizumab-Associated HypophysitisEric Balti, Sarah Verhaeghe, Vibeke Kruse, et al.
JCEM Case Reports|November 1, 2023
Isomorphic (Koebner) Phenomenon Induced by Insulin Analogue Injections in PsoriasisSaartje Thijs, Eric Balti, Corinne Degraeve, et al.
Endocrinology, Diabetes & Metabolism Case Reports|June 4, 2026
Recognising pituitary and thyroid dysfunction after craniospinal radiotherapy: an underrecognised mixed endocrine toxicityKatrien Slabbynck, Stijn Roels, Katrien Erven, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2017
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapyLieve Brochez, Ines Chevolet, Vibeke Kruse
Acta Clinica Belgica|March 23, 2021
Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the keyMichael Saerens, Vibeke Kruse, Willem Lybaert
Trends in Endocrinology and Metabolism: TEM|July 3, 2017
The Significance of Epidermal Lipid Metabolism in Whole-Body PhysiologyVibeke Kruse, Ditte Neess, Nils J Færgeman
Case Reports in Endocrinology|August 11, 2020
Nonmosaic Isodicentric Y Chromosome: A Rare Cause of Azoospermia- From Genetics to Clinical PracticeJolijn Van Cauwenberghe, Sigri Beckers, Peter Coremans
Case Reports in Dermatology|September 7, 2018
Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature ReviewMarlies De Bock, Eva Hulstaert, Vibeke Kruse, et al.
European Journal of Cancer Care|October 5, 2018
Throughput efficiency and service quality after process redesign at a cancer day care unit: Two sides of the coin?Kaat De Pourcq, Paul Gemmel, Jeroen Trybou, et al.
Pageof 6